Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol.

Subject: Liver Disease - PUBLISHED VIA PLOS ONE

Author(s):
Hegde VL, Nagarkatti PS, Nagarkatti M

Department of Pathology, Microbiology and Immunology, University of South Carolina School of Medicine, Columbia, South Carolina, United States of America

 View Source >>

Related Studies:

Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats.

Published via European Journal of Pharmacology

Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death.

Published via Author Manuscript

Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice.

Published via British Journal of Pharmacology

The endocannabinoid system and liver diseases.

Published via Journal of Neuroendocrinology

Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis.

Published via Cell Death & Disease

View all medical studies

Learn More About Cannabis